Allstate Corporation’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$608K Sell
5,550
-4,422
-44% -$630K 0.01% 965
2025
Q4
$1.66M Buy
+9,972
New +$1.67M 0.02% 409

Other funds holding ALAB

Allstate Corporation's ALAB Position: Q1 2026 in Review

Allstate Corporation reduced its Astera Labs (ALAB) stake by 44% in Q1 2026, selling an estimated $630K and leaving 5,550 shares worth $608K. The position accounts for 0.01% of the portfolio, ranked #965.

Allstate Corporation first reported a position in ALAB in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.66M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Allstate Corporation held 5,550 shares of Astera Labs worth $608K as of Q1 2026.
  • Allstate Corporation sold 4,422 Astera Labs shares in Q1 2026, an estimated $630K.
  • Astera Labs made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #965 holding.
  • Allstate Corporation first reported a position in Astera Labs in Q4 2025 and has held it in 2 quarters since.
  • Allstate Corporation's Astera Labs position peaked at $1.66M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.